The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Evdokimov E.Yu.

Central Research Institute of Epidemiology, Moscow, Russia

Sundukov A.V.

Infektsionnaia klinicheskaia bol'nitsa #2, Moskva

Svechnikova E.V.

Lechebno-ozdorovitel'nyĭ tsentr "Eurofemme"

Seborrheic dermatitis in HIV-infected patients

Authors:

Evdokimov E.Yu., Sundukov A.V., Svechnikova E.V.

More about the authors

Read: 19798 times


To cite this article:

Evdokimov EYu, Sundukov AV, Svechnikova EV. Seborrheic dermatitis in HIV-infected patients. Russian Journal of Clinical Dermatology and Venereology. 2019;18(6):728‑734. (In Russ.)
https://doi.org/10.17116/klinderma201918061728

Recommended articles:

References:

  1. Katsambas AD, Lotti TM. European guidelines for the treatment of dermatological diseases. From Engl. M. 2009:459-461. (In Russ.)
  2. Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol. 2003 Mar;139(3):318-322.
  3. Luis J Borda, Tongyu C Wikramanayake. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015 Dec;3(2):10. https://doi.org/10.13188/2373-1044.1000019
  4. Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheic dermatitis. An Bras Dermatol. 2011 Nov-Dec;86(6): 1061-1071.
  5. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ. Fitzpatrick’s Dermatology in General Medicine. Transl. from Engl. Moscow: Panfilov Publishing; BINOM; 2012;Vol. 1:868:235-243. (In Russ.)
  6. Afanasyev YuI, Yurina NA, Kotovsky EF, et al. Histology, embryology, cytology: textbook / ed. Afanasyev YuI, Yurina NA. 6th ed., redesigned and supplemented. M. 2012:800. (In Russ.)
  7. Mauro Picardo, Monica Ottaviani, Emanuela Camera, Arianna Mastrofrancesco. Sebaceous gland lipids. Dermatoendocrinol. 2009 Mar-Apr;1(2):68-71.
  8. Chen YE, Tsao H. The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol. 2013 Jul;69(1):143-155.
  9. Hollander AW. Development of dermatopathology and Paul Gerson Unna. J Am Acad Dermatol. 1986 Oct;15(4 Pt 1):727-734.
  10. Dawson TL Jr. Malassezia globosa and restricta: Breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J Invest Dermatol Symp Proc. 2007;12:15-19.
  11. Gaitanis G, Velegraki A, Mayser P, Bassukas ID. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin Dermatol. 2013 July-Aug;31(4):455-463.
  12. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25:106-141.
  13. Findley K, Grice E. The Skin Microbiome: A Focus on Pathogens and Their Association with Skin Disease. PLOS Pathogens. 2014 Nov;10(11):e1004436.
  14. Rayala BZ, Morrell DS. Common Skin Conditions in Children: Neonatal Skin Lesions. FP essentials 2017 Feb;453:11-17.
  15. Tomida S, Nguyen L, Chiu B, et al. Pan-Genome and Comparative Genome Analyses of Propionibacterium acnes Reveal Its Genomic Diversity in the Healthy and Diseased Human Skin Microbiome. mBio. 2013 May-June; 4(3):e00003-13.
  16. Smith TM, Gilliland K, Clawson GA, Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol. 2008 May 8;128(5):1286-1293.
  17. Krause K, Schnitger A, Fimmel S, et al. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res. 2007;39:166-170.
  18. Smith TM, et al. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol. 2006 Jun;126(6):1226-1232.
  19. Pelle E, McCarthy J, Seltmann H, et al. Identification of histamine receptors and reduction of squalene levels by an antihistamine in sebocytes. J Invest Dermatol. 2008;128:1280-1285.
  20. Smith T, Cong Z, Gilliland K, et al. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol. 2006;126:1226-1232.
  21. Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferators-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol. 2007;156:428-432.
  22. Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. The Journal of Clinical Psychiatry. 1999 Oct;60(10):714-725.
  23. Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson’s disease: a survey of (im) possible links. Med Hypotheses. 2003;60:907-911.
  24. Misery L, Touboul S, Vincot C, et al. Stress and seborrheic dermatitis. Ann Dermatol Venereol. 2007;134:833-837.
  25. Eisenstat BA, Wormser GP. Seborrheic dermatitis and butterfly rash in AIDS. The New England Journal of Medicine. 1984;311:189.
  26. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015 Feb 1;91(3):185-190.
  27. Pokrovsky VI, Pokrovsky VV. HIV infection and AIDS. Clinical recommendations. M. 2010:156. (In Russ.)
  28. Costa A, Nappi RE, Polatti F, Poma A, Grossman AB, Nappi G Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide. Experimental Neurology. 2000 Dec 1;166(2):376-384.
  29. Suh H, Cosenza-Nashat M, Choi N, et al. Insulin-Like Growth Factor 2 Receptor Is an IFNγ-Inducible Microglial Protein that Facilitates Intracellular HIV Replication. The American Journal of Pathology. 2010 Nov;177(5): 2446-2458.
  30. Nakahigashi K, Doi H, Otsuka A, et al. PGD2 induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. Journal of Allergy and Clinical Immunology. 2012 Feb;129(2):536-543.
  31. Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. International Journal of Dermatology. 2007 Oct;46 Suppl 2:14-18.
  32. Passi S, Picardo M, Morrone A, et al. Skin surface lipids in HIV seropositive and HIV sero-negative patients affected with seborrheic dermatitis. J Dermatol Sci. 1991;2:84-91.
  33. Mahmoud A. Ghannoum. Potential Role of Phospholipases in Virulence and Fungal Pathogenesis. Clin Microbiol Rev. 2000 Jan;13(1):122-143.
  34. Sandra Pinto-Cardoso, Nichole R. Klatt, Gustavo Reyes-Terána. Impact of antiretroviral drugs on the microbiome: unknown answers to important questions. Curr Opin HIV AIDS. 2018 Jan;13(1):53-60.
  35. Rincón S, Celis A, Sopó L, et al. Malassezia yeast species isolated from patients with dermatologic lesions. Biomedica. 2005;25:189-195.
  36. Maurer T, et al. The Effect of Highly Active Antiretroviral Therapy on Dermatologic Disease in a Longitudinal Study of HIV Type 1-Infected Women. Clinical Infectious Diseases. 2004 Feb 15;Volume 38, Issue 4:579-584.
  37. Chatzikokkinou P, Sotiropoulos K, Katoulis A, et al. Seborrheic dermatitis — an early and common skin manifestation in HIV patients. Acta Dermatovenerol Croat. 2008;16(4):226-230.
  38. Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. International Journal of Dermatology. 2007 Oct;46 Suppl 2:14-18.
  39. Forrestel AK, Kovarik CL, Mosam A, et al. Diffuse HIV-associated seborrheic dermatitis — a case series. International Journal of STD & AIDS. 2016 Dec;27(14):1342-1345
  40. Dermatovenereology. National leadership, short edition. Edited by Butov YuS, Skripkin YuK, Ivanov OL. M. 2013:896p:605-612. (In Russ.)
  41. Baranov AA, Namazova-Baranova LS, Murashkin NN. Seborrheic dermatitis in children. Clinical recommendations. Approved by the Union of Pediatricians of Russia. M. 2016:27. (In Russ.)
  42. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91:185-190.
  43. Stefanaki I., Katsambas A. Therapeutic Update on Seborrheic Dermatitis. Skin therapy letter, 2010;15(5):1-7.
  44. Dunic I, Vesic S, Jevtovic DJ. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Medicine. 2004 Jan;5(1):50-54.
  45. Szepietowski JC, Reich A, Wesołowska-Szepietowska E, Baran E. National Quality of Life in Dermatology Group. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009 Jul;52(4):357-363.
  46. Kanmani CI, Udayashankar C, Nath AK. Dermatology Life Quality Index in patients infected with HIV: A comparative study. Last accessed on 2014 June 16; Egypt Dermatol Online J. 2013 June;9(1:3):1-11. Available from: http://www.edoj.org.eg/vol009/0901/003/paper.pdf

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.